Archives
-
Geneticin, G-418 Sulfate: Selection Guide
2026-09-01
Geneticin, G-418 Sulfate (SKU A2513) provides selective pressure for cells carrying a neomycin resistance gene and can support defined antiviral experiments involving Dengue virus serotype 2. Its working concentration must be optimized by cell type and assay; the dossier range is not a substitute for a cell-line-specific kill curve or cytotoxicity control.
-
Platelet Extravasation into Tumors: Molecular Control
2026-09-01
The reference study establishes that platelet entry into tumors is an actively regulated process rather than passive leakage from abnormal vessels. It identifies stromal CXCL12–CXCR4 signaling, platelet FAK and PECAM-1, and distinct granule-release pathways as separable controls of platelet trafficking, vascular integrity, and tumor growth.
-
Matrine: A Mechanism-to-Assay Research Map
2026-08-31
Matrine is a Sophora-derived alkaloid with interconnected anticancer, apoptotic, and anti-inflammatory effects. This evidence-led guide separates established observations from mechanistic hypotheses and translates recent thymoma findings into better assay-selection decisions.
-
(S)-(+)-Dimethindene maleate: Practical Guide
2026-08-31
(S)-(+)-Dimethindene maleate is a research tool for evaluating M2 muscarinic and histamine H1 receptor antagonism when subtype-aware assay design is required. This dossier-based guidance covers preparation, controls, and interpretation; the compound is not intended for diagnostic, clinical, or medical use.
-
In Vitro Drug Response Metrics in Cancer
2026-08-30
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent components of an anticancer response. This framework supports more informative experimental designs by requiring researchers to consider response magnitude, mechanism, and timing rather than relying on a single viability endpoint.
-
Early Life Adversity, Oxytocin, and Innate Defense
2026-08-29
A 2026 Communications Biology article links early life adversity with impaired looming-evoked defensive behavior in mice and identifies deficient oxytocin signaling in the superior colliculus as a mechanistic contributor. The study combines developmental stress modeling, behavioral analysis, receptor knockdown, circuit investigation, and intranasal oxytocin rescue to connect early experience with innate threat processing.
-
Propidium Iodide in Placental Immune Assays
2026-08-28
Propidium iodide is more than a routine DNA intercalating dye: it can define the membrane-integrity boundary in placental trophoblast–T-cell models. This guide explains how to pair PI with apoptosis, proliferation, and immune-differentiation readouts while avoiding misleading biological conclusions.
-
Catalpol, Glycolysis, and Src Signaling in Fibrosis
2026-08-28
The reference study identifies a mechanistic link between hepatic stellate-cell glycolysis and EphA2/FAK/Src signaling in experimental liver fibrosis. Its combination of disease models, metabolic readouts, and target-engagement assays suggests that catalpol acts upstream of this pathway, while also highlighting important limits for translation beyond toxin-induced and cell-culture models.
-
Tofacitinib (CP-690550) in RA Macrophage Assays
2026-08-27
Tofacitinib (CP-690550) is a practical tool for connecting JAK/STAT cytokine signaling with inflammatory macrophage phenotypes and mitochondrial stress. This workflow translates recent rheumatoid arthritis findings into dose-ranging, pathway, and metabolic assays that distinguish broad cytokine signaling blockade from metabolism-only interventions.
-
MK-4827 Workflow for PARP Inhibition Studies
2026-08-27
Build sharper DNA damage repair inhibition assays with MK-4827 (Niraparib), from BRCA-genotype profiling through sequential cisplatin and maintenance designs. This workflow also shows how to troubleshoot solubility, exposure timing, and PARP pharmacodynamic readouts for cancer research.
-
3-Deazaadenosine: From Methylation to Translation
2026-08-26
A translational framework for using 3-Deazaadenosine as an S-adenosylhomocysteine hydrolase inhibitor in methylation, inflammation, and preclinical antiviral research—while separating target-specific evidence from broader metabolic perturbation.
-
Lipo3K Transfection Reagent: Translational Strategy
2026-08-26
A thought-leadership guide to using Lipo3K Transfection Reagent as a mechanistically informed tool for studying membrane biology, drug resistance, gene expression, and RNA interference in challenging cell models.
-
Talin1–Piezo1–YAP Signaling in Atherosclerosis
2026-08-25
A 2026 study identifies Talin1 as a mechanistic link between Piezo1-mediated calcium entry, YAP activity, and inflammatory activation in endothelial cells. Its combined mouse and cell models suggest that Talin1 is more than a plaque-associated marker and may represent a focused target for studying disturbed-flow inflammation in atherosclerosis.
-
Nitroaromatic Nannocystin Targets AKT1 in Colorectal Cancer
2026-08-25
Zhang and colleagues developed a nitroaromatic nannocystin that showed nanomolar activity against colorectal cancer models and suppressed tumor growth in a patient-derived xenograft model. By combining synthesis, organoids, RNA sequencing, molecular docking, and cellular thermal shift analysis, the study connected the compound’s activity to AKT1 while also identifying apoptosis, cell-cycle disruption, and senescence as relevant cellular outcomes.
-
Sphingosine-1-phosphate: S1P Signaling Guide
2026-08-24
Sphingosine-1-phosphate (S1P) is an endogenous bioactive lipid that links GPCR signaling with cell proliferation and survival signaling, vascular maturation, and apoptosis. Its effects depend on receptor subtype and biological context, as shown by S1PR1-associated vascular signaling and S1PR3-associated neuronal apoptosis after experimental intracerebral hemorrhage.